Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 1;9(6):220285.
doi: 10.1098/rsos.220285. eCollection 2022 Jun.

Application of sulfur and nitrogen doped carbon quantum dots as sensitive fluorescent nanosensors for the determination of saxagliptin and gliclazide

Affiliations

Application of sulfur and nitrogen doped carbon quantum dots as sensitive fluorescent nanosensors for the determination of saxagliptin and gliclazide

Galal Magdy et al. R Soc Open Sci. .

Abstract

In this study, highly fluorescent sulfur and nitrogen doped carbon quantum dots (S,N-CQDs) were used as fluorescent nanosensors for direct spectrofluorimetric estimation of each of gliclazide (GLZ) and saxagliptin (SXG) without any pre-derivatization steps for the first time. S,N-CQDs were synthesized employing a simple hydrothermal technique using citric acid and thiosemicarbazide. The produced S,N-CQDs were characterized using different techniques including fluorescence emission spectroscopy, UV spectrophotometry, high-resolution transmission electron microscopy and FT-IR spectroscopy. Following excitation at 360 nm, S,N-CQDs exhibited a strong emission peak at 430 nm. The native fluorescence of S,N-CQDs was quantitatively enhanced by addition of increased concentrations of the studied drugs. The fluorescence enhancement of S,N-CQDs and the concentrations of the studied drugs revealed a wide linear relationship in the range of 30.0-500.0 µM and 75.0-600.0 µM with limits of detection of 5.0 and 10.15 µM for GLZ and SXG, respectively. The proposed method was efficiently used for determination of cited drugs in their commercial tablets with % recoveries ranging from 98.6% to 101.2% and low % relative standard deviation values (less than 2%). The mechanism of interaction between S,N-CQDs and the two drugs was studied. Validation of the proposed method was carried out in accordance with International Conference on Harmonization (ICH) guidelines.

Keywords: fluorescent nanosensors; gliclazide; saxagliptin; sulfur and nitrogen–carbon quantum dots; tablets.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1.
Figure 1.
Structural formulae of GLZ (a) and SXG (b).
Figure 2.
Figure 2.
(A) UV absorption spectra of citric acid (a), thiosemcarbazide (b) and S,N-CQDs (c); (B) fluorescence excitation and emission spectra of S,N-CQDs; (C) fluorescence spectra of S,N-CQDs at different excitation wavelengths.
Figure 3.
Figure 3.
(a) The typical HRTEM images of S,N-CQDs; (b) FT-IR spectra of N,S-CQDs.
Figure 4.
Figure 4.
Fluorescence emission spectra of S,N-CQDs in aqueous solution upon addition of various concentrations of GLZ (from bottom to top: 0, 30.0, 40.0, 100.0, 150.0, 200.0, 300.0, 400.0, 500.0 µM).
Figure 5.
Figure 5.
Fluorescence emission spectra of S,N-CQDs in aqueous solution upon addition of various concentrations of SXG (from bottom to top: 0, 75.0, 100.0, 150.0, 200.0, 300.0, 400.0, 500.0, 600.0 µM).
Figure 6.
Figure 6.
(A) A co-plot showing that there is no overlap between fluorescence excitation spectrum of the S,N-CQDs (a) and the UV–Vis absorption spectrum of the GLZ (500.0 µM) (b); (B) A co-plot showing that there is no overlap between fluorescence excitation spectrum of the S,N-CQDs (a) and the UV–Vis absorption spectrum of the SXG (600.0 µM) (c).
Figure 7.
Figure 7.
Effect of pH (A), incubation time (B) and temperature (C) on the enhancement of the fluorescence intensity of S,N-CQDs by GLZ (300.0 µM) (a), SXG (200.0 µM) (b).

Similar articles

Cited by

References

    1. Sweetman SC, Blake P. 2011. Martindale: the complete drug reference. 33. London, UK: Pharmaceutical Press.
    1. Panigrahi R, Behera S, Choudhury PK, Mishra G. 2012. Development of new spectrophotometric method for the estimation of gliclazide. Int. J. Adv. Pharm. Biol. Sci. 2, 124-127.
    1. Kim S, et al. 2016. PubChem substance and compound databases. Nucleic Acids Res. Spec. Publ. 44, D1202-D1213. (10.1093/nar/gkv951) - DOI - PMC - PubMed
    1. Augeri DJ, et al. 2005. Discovery and preclinical profile of saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. J. Med. Chem. 48, 5025-5037. (10.1021/jm050261p) - DOI - PubMed
    1. Gedawy A, Al-Salami H, Dass CR. 2019. Development and validation of a new analytical HPLC method for simultaneous determination of the antidiabetic drugs, metformin and gliclazide. J. Food Drug Anal. 27, 315-322. (10.1016/j.jfda.2018.06.007) - DOI - PMC - PubMed

LinkOut - more resources